Maarten J. van Tol

746 citations

17 papers · 571 indexed · h-index 11

Immunology top 10%
Genetics top 10%
Epidemiology
Radiology, Nuclear Medicine and Imaging top 10%
Molecular Biology

Co-authors: Arjan C. Lankester René E. M. Toes Jaak M. Vossen Marco W. Schilham Bianca Heemskerk Eric C. J. Claas Aloys C.M. Kroes Marcela Echavarría
Topics: Immunodeficiency and Autoimmune Disorders (7 papers)Monoclonal and Polyclonal Antibodies Research (4 papers)Virus-based gene therapy research (3 papers)
Cited by: Immunology Hematology Genetics
Journals: Blood The Journal of Immunology Clinical Infectious Diseases
Partner nations: Netherlands United States Austria

In The Last Decade

Maarten J. van Tol

17 papers receiving 557 citations

Peers

Countries citing papers authored by Maarten J. van Tol

Since Specialization

Citations

This map shows the geographic impact of Maarten J. van Tol's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Maarten J. van Tol with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Maarten J. van Tol more than expected).

Fields of papers citing papers by Maarten J. van Tol

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Maarten J. van Tol. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Maarten J. van Tol. The network helps show where Maarten J. van Tol may publish in the future.

Co-authorship network of co-authors of Maarten J. van Tol

This figure shows the co-authorship network connecting the top 25 collaborators of Maarten J. van Tol. A scholar is included among the top collaborators of Maarten J. van Tol based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Maarten J. van Tol. Maarten J. van Tol is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

17 of 17 papers shown

#	Work	Indexed citations
1	Recurrent respiratory tract infections (RRTI) in the elderly: A late onset mild immunodeficiency? 2017 ·Clinical Immunology ·Esther van de Vosse,Monique M. van Ostaijen-ten Dam,(unknown),(unknown),(unknown),Jaap Bakker,(unknown),Hermann Eibel,Maarten J. van Tol,Jaap T. van Dissel,Margje H. Haverkamp	7
2	Identification of the Common Origins of Osteoclasts, Macrophages, and Dendritic Cells in Human Hematopoiesis 2015 ·Stem Cell Reports ·Yanling Xiao,(unknown),Liqin Wang,(unknown),Maarten J. van Tol,Arjan C. Lankester,Jannie Borst	42
3	Avidity maturation of ACPA in rheumatoid arthritis. 2011 ·Data Archiving and Networked Services (DANS) ·Parawee Suwannalai,Lotte A van de Stadt,Helga Radner,G Steiner,Hani El‐Gabalawy,Cornelia M. Jol‐van der Zijde,Maarten J. van Tol,Dirkjan van Schaardenburg,T. Huizinga,René E. M. Toes,Leendert A. Trouw	1
4	Avidity maturation of anti–citrullinated protein antibodies in rheumatoid arthritis 2011 ·Arthritis & Rheumatism ·Parawee Suwannalai,Lotte A van de Stadt,Helga Radner,G Steiner,Hani El‐Gabalawy,Cornelia M. Jol‐van der Zijde,Maarten J. van Tol,Dirkjan van Schaardenburg,T. Huizinga,René E. M. Toes,Leendert A. Trouw	88
5	Combined CD8+ and CD4+ adenovirus hexon-specific T cells associated with viral clearance after stem cell transplantation as treatment for adenovirus infection 2010 ·Haematologica ·Maarten L. Zandvliet,J.H. Frederik Falkenburg,Ellis van Liempt,Louise A. Veltrop‐Duits,Arjan C. Lankester,Jayant Kalpoe,(unknown),Dirk M. van der Steen,Maarten J. van Tol,Roel Willemze,Henk‐Jan Guchelaar,Marco W. Schilham,Pauline Meij	54
6	IMPAIRED AVIDITY MATURATION AFTER TETANUS TOXOID BOOSTER IN CHILDREN WITH DOWN SYNDROME 2010 ·The Pediatric Infectious Disease Journal ·Maaike Kusters,Cornelia M. Jol‐van der Zijde,Maarten J. van Tol,(unknown),Levinus A. Bok,(unknown),Esther de Vries	20
7	Combined CD8+ and CD4+ adenovirus hexon-specific T cells associated with viral clearance after stem cell transplantation as treatment for adenovirus infection Running head: M. Zandvliet et al. HAdV-specific T cells after alloSCT 2010 ·Maarten L. Zandvliet,Ellis van Liempt,Louise A. Veltrop‐Duits,Arjan C. Lankester,Jayant Kalpoe,Dirk M. van der Steen,Maarten J. van Tol,Roel Willemze,Henk‐Jan Guchelaar,Marco W. Schilham,Pauline Meij	2
8	Anti-citrullinated protein antibodies have a low avidity compared to antibodies against recall-antigens 2010 ·Annals of the Rheumatic Diseases ·Parawee Suwannalai,Hans Ulrich Scherer,Diane van der Woude,A. Ioan-Facsinay,(unknown),Maarten J. van Tol,T. Huizinga,René E. M. Toes,Leendert A. Trouw	1
9	Early determinants of long-term T-cell reconstitution after hematopoietic stem cell transplantation for severe combined immunodeficiency 2006 ·Blood ·José A. M. Borghans,Robbert G. M. Bredius,Mette D. Hazenberg,Helene Roelofs,(unknown),J Heidt,Sigrid A. Otto,Taco W. Kuijpers,Willem E. Fibbe,Jaak M. Vossen,Frank Miedema,Maarten J. van Tol	56
10	High Levels of Adenovirus DNA in Serum Correlate with Fatal Outcome of Adenovirus Infection in Children after Allogeneic Stem‐Cell Transplantation 2002 ·Clinical Infectious Diseases ·Marco W. Schilham,Eric C. J. Claas,(unknown),Bianca Heemskerk,Jaak M. Vossen,Arjan C. Lankester,René E. M. Toes,Marcela Echavarría,Aloys C.M. Kroes,Maarten J. van Tol	125
11	[Immunology in medical practice. XXXV. Screening of suspected immunodeficiency: diagnostic protocols for patients with opportunistic or recurrent severe infections, wasting and failure to thrive]. 2000 ·PubMed ·Esther de Vries,Taco W. Kuijpers,Maarten J. van Tol,J W van der Meer,(unknown),Jacques J. M. van Dongen	7
12	[Immunology in medical practice. XXXIV. Screening for suspected immunodeficiency: Introduction]. 2000 ·PubMed ·Esther de Vries,Taco W. Kuijpers,Maarten J. van Tol,J W van der Meer,(unknown),Jacques J. M. van Dongen	7
13	Glutamic Acid Decarboxylase Antibodies in Screening for Autoimmune Diabetes: Influence of Comorbidity, Age, and Sex on Specificity and Threshold Values 1999 ·Clinical Chemistry ·Manou R. Batstra,(unknown),Jacob Petersen,Cees A. van Donselaar,Maarten J. van Tol,G.J. Bruining,Diederick E. Grobbee,Thomas Dyrberg,Henk‐Jan Aanstoot	15
14	A triallelic Fc γ receptor type IIIA polymorphism influences the binding of human IgG by NK cell Fc γ RIIIa 1996 ·The Journal of Immunology ·Masja de Haas,(unknown),Marion Kleijer,Evert de Vries,Suat Şimşek,Maarten J. van Tol,Dirk Roos,A E von dem Borne	90
15	Human T cell repertoire generation in the absence of MHC class II expression results in a circulating CD4+CD8- population with altered physicochemical properties of complementarity-determining region 3 1996 ·The Journal of Immunology ·(unknown),(unknown),Anette H.H. van Boxel-Dezaire,R.F. Schipper,(unknown),Ad Peijnenburg,Özden Sanal,F Ersoy,Ger T. Rijkers,B.J.M. Zegers,Jaak M. Vossen,Maarten J. van Tol,Peter J. van den Elsen	12
16	Expression pattern of the most JH-proximal human VH gene segment (VH6) in the B cell and antibody repertoire suggests a role of VH6-encoded IgM antibodies in early ontogeny 1993 ·The Journal of Immunology ·Johan H. van Es,Frank M. Raaphorst,Maarten J. van Tol,Frits H.J. Gmelig Meyling,Ton Logtenberg	25
17	Distinct role of neonatal and adult monocytes in the regulation of the in vitro antigen-induced plaque-forming cell response in man. 1984 ·The Journal of Immunology ·Maarten J. van Tol,Jan G. Zijlstra,Christopher M. Thomas,B.J.M. Zegers,R. E. Ballieux	19

About Maarten J. van Tol

Maarten J. van Tol is a scholar working on Immunology, Emergency Medical Services and Hematology, having authored 17 papers that have together received 571 indexed citations. Recurring topics across this work include Immunodeficiency and Autoimmune Disorders (7 papers), Monoclonal and Polyclonal Antibodies Research (4 papers) and Virus-based gene therapy research (3 papers). The work is most often cited by research in Immunology (255 citations), Hematology (81 citations) and Genetics (182 citations). Maarten J. van Tol has collaborated with scholars based in Netherlands, United States and Austria. Frequent co-authors include Arjan C. Lankester, René E. M. Toes, Jaak M. Vossen, Marco W. Schilham, Bianca Heemskerk, Eric C. J. Claas, Aloys C.M. Kroes, Marcela Echavarría, Dirk Roos and Cornelia M. Jol‐van der Zijde. Their work appears in journals such as Blood, The Journal of Immunology and Clinical Infectious Diseases.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact